Loading...
XKRX027360
Market cap195mUSD
Dec 30, Last price  
2,430.00KRW
1D
1.67%
1Q
21.99%
IPO
101.66%
Name

AJU IB INVESTMENT CO LTD

Chart & Performance

D1W1MN
XKRX:027360 chart
P/E
17.32
P/S
5.35
EPS
140.32
Div Yield, %
0.82%
Shrs. gr., 5y
1,072.44%
Rev. gr., 5y
23.69%
Revenues
53.74b
+125.82%
22,618,598,68050,586,619,38074,202,757,65060,233,546,51565,471,966,05631,462,440,88318,565,485,07935,224,298,75934,440,026,62859,382,100,88523,798,297,25553,740,827,750
Net income
16.60b
+714.19%
-5,805,914,0706,524,479,5509,626,506,18011,680,024,09715,087,852,43116,113,088,79614,562,286,37316,288,676,49549,437,362,10039,333,565,4302,039,024,79016,601,630,818
CFO
24.88b
+12.22%
30,569,32025,496,704,73028,348,397,29065,178,233,85528,482,612,508-3,733,738,716-8,550,201,91125,933,976,566-3,078,743,09856,982,108,88522,168,831,93224,877,668,729
Dividend
Dec 27, 202320 KRW/sh

Profile

Aju IB Investment Co., Ltd. is a venture capital and private equity arm of AJU Corporation Co., Ltd. It specializes in mezzanine, buyouts, corporate restructuring, and all stages of venture investments in small to medium sized start-up companies in South Korea. The firm considers investments in information technology including mobile service platforms, software, semiconductor, contents, biotechnology, life science, and environment sectors. For venture capital investments, it focuses on high technology sector and for private equity investments, the firm focuses on manufacturing sector. It typically invests in South Korea but also makes investments in other countries. The firm also considers investments in companies with main business in immune system platform technology, oncology drugs, and ophthalmic drugs. It also invests in information communication technology including Internet of Things, artificial intelligence, smart car, and advanced materials. The firm considers investments in companies that have been evaluated by technology credit bureaus or in companies with ratings of T5 and above, which is provided by technology credit bureaus. For the investments by the office in Boston, Massachusetts, the firm primarily invests in therapeutics serving large unmet medical need; enabling platform technologies with maturing lead candidate; potential for partnership or alliance with Korean pharmaceutical companies; other areas of interest are medical devices & diagnostics. It prefers to invest between $0.87 million to $2.61 million for venture capital investments and $4.36 million to $17.45 million for private equity investments. The firm typically exits through IPO and mergers and acquisitions. Aju IB Investment Co., Ltd., formerly known as Kibo Technology Advancing Capital Co., was founded in 1974 and is based in Seoul, South Korea with an additional office in Boston, Massachusetts.
IPO date
Nov 21, 2018
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
53,740,828
125.82%
23,798,297
-59.92%
Cost of revenue
4,683,331
15,579,907
Unusual Expense (Income)
NOPBT
49,057,496
8,218,390
NOPBT Margin
91.29%
34.53%
Operating Taxes
1,147,176
2,486,013
Tax Rate
2.34%
30.25%
NOPAT
47,910,321
5,732,377
Net income
16,601,631
714.19%
2,039,025
-94.82%
Dividends
(2,358,810)
(11,795,402)
Dividend yield
0.72%
4.44%
Proceeds from repurchase of equity
32,104
BB yield
-0.01%
Debt
Debt current
1,678,453
Long-term debt
29,658,139
38,230,533
Deferred revenue
1,346,250
1,982,191
Other long-term liabilities
72,109,647
71,114,306
Net debt
(245,099,910)
(298,945,759)
Cash flow
Cash from operating activities
24,877,669
22,168,832
CAPEX
(106,539)
(651,774)
Cash from investing activities
9,004,400
(20,099,385)
Cash from financing activities
(31,511,879)
(13,329,173)
FCF
37,888,548
(6,053,721)
Balance
Cash
36,522,351
45,034,623
Long term investments
238,235,698
293,820,123
Excess cash
272,071,008
337,664,831
Stockholders' equity
273,779,971
454,087,819
Invested Capital
71,540,229
12,471,879
ROIC
114.06%
234.09%
ROCE
13.83%
2.26%
EV
Common stock shares outstanding
118,526
119,912
Price
2,750.00
24.15%
2,215.00
-44.63%
Market cap
325,947,523
22.72%
265,605,341
-42.71%
EV
117,093,537
192,083,684
EBITDA
51,004,026
9,886,305
EV/EBITDA
2.30
19.43
Interest
1,662,489
1,314,148
Interest/NOPBT
3.39%
15.99%